(0.25%) 5 535.25 points
(0.26%) 39 572 points
(0.25%) 19 977 points
(0.65%) $82.07
(-1.81%) $2.55
(0.35%) $2 347.70
(0.19%) $29.62
(-0.71%) $994.80
(-0.25%) $0.931
(-0.30%) $10.64
(-0.18%) $0.789
(2.07%) $87.50
Live Chart Being Loaded With Signals
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital...
Stats | |
---|---|
Šios dienos apimtis | 1.48M |
Vidutinė apimtis | 584 870 |
Rinkos kapitalizacija | 4.22B |
EPS | $0.400 ( Q4 | 2024-05-20 ) |
Kita pelno data | ( $1.030 ) 2024-08-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
36.13 (Sector) 49.64 (Industry) 36.61 |
ATR14 | $0.0920 (0.11%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-06 | Simon, Christopher | Buy | 104 516 | Common Stock |
2024-06-06 | Simon, Christopher | Sell | 71 335 | Common Stock |
2024-06-06 | Simon, Christopher | Sell | 104 516 | Non-qualified Stock Option (Right to Buy) |
2024-05-28 | Lingamneni Anila | Buy | 14 140 | Common Stock |
2024-05-28 | Lingamneni Anila | Sell | 5 279 | Common Stock |
INSIDER POWER |
---|
0.52 |
Last 99 transactions |
Buy: 624 425 | Sell: 674 394 |
Tūris Koreliacija
Haemonetics Corp Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
OAK-PA | 0.927 |
RTO | 0.908 |
OAK-PB | 0.907 |
MNSO | 0.898 |
LMT | 0.896 |
ECC-PD | 0.891 |
YMM | 0.889 |
CRK | 0.887 |
AEM | 0.884 |
SCHW | 0.879 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
GEV | -0.926 |
ULS | -0.907 |
INFY | -0.905 |
HAFN | -0.902 |
KNX | -0.896 |
MSCI | -0.878 |
SDP | -0.877 |
ACN | -0.876 |
KLG | -0.869 |
TCI | -0.863 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Haemonetics Corp Koreliacija - Valiuta/Žaliavos
Haemonetics Corp Finansinės ataskaitos
Annual | 2024 |
Pajamos: | $1.31B |
Bruto pelnas: | $676.54M (51.68 %) |
EPS: | $2.32 |
FY | 2024 |
Pajamos: | $1.31B |
Bruto pelnas: | $676.54M (51.68 %) |
EPS: | $2.32 |
FY | 2023 |
Pajamos: | $1.17B |
Bruto pelnas: | $615.10M (52.63 %) |
EPS: | $2.27 |
FY | 2023 |
Pajamos: | $1.17B |
Bruto pelnas: | $615.10M (52.63 %) |
EPS: | $0 |
Financial Reports:
Symbol | Period | Year | Title |
---|---|---|---|
HAE | Q4 | 2024 | Haemonetics Corporation Q4 2024 Financial Results |
HAE | FY | 2024 | Haemonetics Corporation Q4 2024 Financial Report |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Haemonetics Corp
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.